Y0002276

Dipotassium clorazepate monohydrate

European Pharmacopoeia (EP) Reference Standard

• Synonym(s): Clorazepate dipotassium salt, 7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid
• Linear Formula: C₁₆H₁₁ClN₂O₄K₂
• CAS Number: 57109-90-7
• Molecular Weight: 408.92
• UNSPSC Code: 41116107
• NACRES: NA.24

Properties

• API family: clorazepate
• manufacturer/tradename: EDQM
• storage temp.: 2-8°C
• SMILES string: ClC1=CC=C2C(C(C3=CC=CC=C3)=NC(C(O[K])=O)C(N2)=O)=C1.[K]O
• InChI: 1S/C16H11ClN2O3.2K.H2O/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;;;/h1-8,14H,(H,18,20)(H,21,22);;;1H2/q;2*+1;/p-2
• InChI key: QCHSEDTUUKDTIG-UHFFFAOYSA-L

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Dipotassium clorazepate monohydrate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Safety Information

• Pictograms: GHS08,GHS07
• Signal Word: Warning
• Hazard Statements: H302,H361
• Precautionary Statements: P202 - P264 - P270 - P280 - P301 + P312 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Repr. 2
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable